Articles producció científica> Medicina i Cirurgia

The pharmacological management of cardiovascular disease in people living with HIV (PLWH)

  • Identification data

    Identifier: imarina:9139040
    Authors:
    Corbacho NMur IMolas MEVidal FDomingo P
    Abstract:
    © 2020 Informa UK Limited, trading as Taylor & Francis Group. ABSTARCT: Introduction: Cardiovascular disease (CVD) continues to be an essential cause of morbidity and mortality among people living with human immunodeficiency virus infection (PLWH). Since the bulk of cardiovascular risk (CVR) factors are shared between PLWH and the general population, prevention and treatment strategies are similar. However, there are CVR factors particular to PLWH, which need separate consideration. These factors are those HIV-dependent, those related to HIV-derived consequences, and combination antiretroviral therapy (cART)-dependent. Areas covered: In this review, the authors discuss the management of CVD in PLWH, with a special interest in pharmacological treatment and drug-drug interactions with cART. Expert opinion: In recent years, we have witnessed a decreased CVD morbidity and mortality in PLWH, which probably reflects an improvement in the management of CVR factors and CVD in these patients, partially thanks to new developments in antiretroviral therapy. Therefore, although there is still room for improvement, at present, the old desideratum of equaling PLWH and the general population in terms of CVD incidence and prognosis is a little closer.
  • Others:

    Author, as appears in the article.: Corbacho N; Mur I; Molas ME; Vidal F; Domingo P
    Department: Medicina i Cirurgia
    URV's Author/s: Vidal Marsal, Francisco
    Keywords: Triglycerides Statins People living with hiv Obesity Dyslipidaemia Drug-drug interactions Diabetes mellitus Colesterol Cardiovascular risk Cardiovascular disease Arterial hypertension triglycerides statins obesity dyslipidaemia drug-drug interactions diabetes mellitus colesterol cardiovascular risk cardiovascular disease arterial hypertension
    Abstract: © 2020 Informa UK Limited, trading as Taylor & Francis Group. ABSTARCT: Introduction: Cardiovascular disease (CVD) continues to be an essential cause of morbidity and mortality among people living with human immunodeficiency virus infection (PLWH). Since the bulk of cardiovascular risk (CVR) factors are shared between PLWH and the general population, prevention and treatment strategies are similar. However, there are CVR factors particular to PLWH, which need separate consideration. These factors are those HIV-dependent, those related to HIV-derived consequences, and combination antiretroviral therapy (cART)-dependent. Areas covered: In this review, the authors discuss the management of CVD in PLWH, with a special interest in pharmacological treatment and drug-drug interactions with cART. Expert opinion: In recent years, we have witnessed a decreased CVD morbidity and mortality in PLWH, which probably reflects an improvement in the management of CVR factors and CVD in these patients, partially thanks to new developments in antiretroviral therapy. Therefore, although there is still room for improvement, at present, the old desideratum of equaling PLWH and the general population in terms of CVD incidence and prognosis is a little closer.
    Thematic Areas: Saúde coletiva Pharmacology (medical) Pharmacology & pharmacy Pharmacology Medicine (miscellaneous) Medicina iii Medicina ii Medicina i General medicine Farmacia Ciências biológicas ii
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: francesc.vidal@urv.cat
    Author identifier: 0000-0002-6692-6186
    Record's date: 2024-07-27
    Papper version: info:eu-repo/semantics/acceptedVersion
    Link to the original source: https://www.tandfonline.com/doi/full/10.1080/14656566.2020.1856075?scroll=top&needAccess=true
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Expert Opinion On Pharmacotherapy. (6): 743-753
    APA: Corbacho N; Mur I; Molas ME; Vidal F; Domingo P (2021). The pharmacological management of cardiovascular disease in people living with HIV (PLWH). Expert Opinion On Pharmacotherapy, (6), 743-753. DOI: 10.1080/14656566.2020.1856075
    Article's DOI: 10.1080/14656566.2020.1856075
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2021
    Publication Type: Journal Publications
  • Keywords:

    Medicine (Miscellaneous),Pharmacology,Pharmacology & Pharmacy,Pharmacology (Medical)
    Triglycerides
    Statins
    People living with hiv
    Obesity
    Dyslipidaemia
    Drug-drug interactions
    Diabetes mellitus
    Colesterol
    Cardiovascular risk
    Cardiovascular disease
    Arterial hypertension
    triglycerides
    statins
    obesity
    dyslipidaemia
    drug-drug interactions
    diabetes mellitus
    colesterol
    cardiovascular risk
    cardiovascular disease
    arterial hypertension
    Saúde coletiva
    Pharmacology (medical)
    Pharmacology & pharmacy
    Pharmacology
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    General medicine
    Farmacia
    Ciências biológicas ii
  • Documents:

  • Cerca a google

    Search to google scholar